Signos gets FDA green light for over-the-counter CGM for weight management
August 20, 2025
Signos today announced a major step forward in bringing over-the-counter (OTC) continuous glucose monitoring (CGM) to market.
Signos today announced a major step forward in bringing over-the-counter (OTC) continuous glucose monitoring (CGM) to market.
Microbot Medical (Nasdaq:MBOT) announced today that it received a new patent covering a modular robotic surgical system.